ReviewImmunoTargets and therapy2024

Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis.

Guanlian Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.